These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 7714814

  • 1. Carvedilol, a new beta-adrenoreceptor blocker, vasodilator and free-radical scavenger, exerts an anti-shock and endothelial protective effect in rat splanchnic ischemia and reperfusion.
    Christopher TA, Lopez BL, Yue TL, Feuerstein GZ, Ruffolo RR, Ma XL.
    J Pharmacol Exp Ther; 1995 Apr; 273(1):64-71. PubMed ID: 7714814
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of a hydroxylated metabolite of the beta-andrenoreceptor antagonist, carvedilol, on post-ischaemic splachnic tissue injury.
    Christopher TA, Lopez BL, Ma XL, Feuerstein GZ, Ruffolo RR, Yue TL.
    Br J Pharmacol; 1998 Jan; 123(2):292-8. PubMed ID: 9489618
    [Abstract] [Full Text] [Related]

  • 5. L-propionyl carnitine, an endogenous ester in fatty acid metabolism, exerts anti-shock and endothelial protective effects in rat splanchnic ischemia-reperfusion injury.
    Stroh R, Christopher TA, Lopez BL, Guo YP, Amico-Roxas M, Ma XL.
    Shock; 1998 Mar; 9(3):216-22. PubMed ID: 9525330
    [Abstract] [Full Text] [Related]

  • 6. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
    Yue TL, Cheng HY, Lysko PG, McKenna PJ, Feuerstein R, Gu JL, Lysko KA, Davis LL, Feuerstein G.
    J Pharmacol Exp Ther; 1992 Oct; 263(1):92-8. PubMed ID: 1357162
    [Abstract] [Full Text] [Related]

  • 7. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion.
    Cuzzocrea S, Zingarelli B, Costantino G, Szabó A, Salzman AL, Caputi AP, Szabó C.
    Br J Pharmacol; 1997 Jul; 121(6):1065-74. PubMed ID: 9249240
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion.
    Cuzzocrea S, Mazzon E, Dugo L, Caputi AP, Aston K, Riley DP, Salvemini D.
    Br J Pharmacol; 2001 Jan; 132(1):19-29. PubMed ID: 11156557
    [Abstract] [Full Text] [Related]

  • 11. Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat.
    Smith EF, Griswold DE, Hillegass LM, Slivjak MJ, Davis PA, DiMartino MJ.
    Pharmacology; 1992 Jan; 44(6):297-305. PubMed ID: 1354874
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
    Asanuma H, Minamino T, Sanada S, Takashima S, Ogita H, Ogai A, Asakura M, Liao Y, Asano Y, Shintani Y, Kim J, Shinozaki Y, Mori H, Node K, Kitamura S, Tomoike H, Hori M, Kitakaze M.
    Circulation; 2004 Jun 08; 109(22):2773-9. PubMed ID: 15148268
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
    Ruffolo RR, Feuerstein GZ.
    Cardiovasc Drugs Ther; 1997 May 08; 11 Suppl 1():247-56. PubMed ID: 9211017
    [Abstract] [Full Text] [Related]

  • 18. Carvedilol preserves endothelial junctions and reduces myocardial no-reflow after acute myocardial infarction and reperfusion.
    Zhao J, Yang Y, you S, Cui C, Gao R.
    Int J Cardiol; 2007 Feb 14; 115(3):334-41. PubMed ID: 16824628
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Carvedilol attenuates ischemia-reperfusion-induced oxidative renal injury in rats.
    Singh D, Chander V, Chopra K.
    Fundam Clin Pharmacol; 2004 Dec 14; 18(6):627-34. PubMed ID: 15548233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.